The interventional pain billing guidelines 2026 require multi-physician pain groups and ASCs to immediately adapt to three compounding revenue threats: a CMS-finalized -2.5% efficiency adjustment on non-time-based procedure RVUs, mandatory prior authorization for Epidural Steroid Injections under the WISeR Model effective January 1, 2026, and a site-of-service payment differential that reduces facility-based indirect practice expense […]
Are Your Interventional Pain Billing Guidelines Costing You Revenue?









